A. R. Felty (1924) described 5 cases of chronic rheumatoid arthritis with splenomegaly and leucopenia. Since then this syndrome has become increasingly recognized and occurs in about 1 % of patients with rheumatoid arthritis (Short, Bauer, and Reynolds, 1957) . Leucopenia that occurs is almost exclusively the result of a reduction in granulocyte numbers in the peripheral blood. The mechanism whereby this occurs is unknown. None of the various theories put forth to explain the granulocytopenia been satisfactory. Those that have been suggested are chronic sepsis (Singer and Levy, 1936) , sequestration of white blood cells by hypersplenism (Hirschboeck, 1946; Wright, Doan, Bouroncle, and Zollinger, 1951) , and inhibition of normal granulocytes by a splenic factor (Hutchison and Alexander, 1954) . The most commonly accepted mechanism is hypersplenism with sequestration of peripheral granulocytes and their subsequent destruction in this organ. A common recurrence of granulocytopenia after splenectomy suggests, however, that this is not the only mechanism involved in the development of this disorder, and indicates that extrasplenic factors must be involved (Ruderman, Miller, and Pinals, 1968) . In some patients white blood cell antinuclear factors have been shown (Faber, Elling, Norup, Mansa, and Nissen, 1964; Barnes, Turnbull, and VernonRoberts, 1971) Robinson. and form colonies of granulocytes and macrophages in a semisolid tissue culture medium in the presence of an appropriate stimulus (Pluznik and Sachs, 1965; Bradley and Metcalf, 1966) . This system has been used extensively to study factors affecting and regulating granulocyte maturation and production. Using this system, Greenberg and Schrier (1973) have recently shown that the number ofgranulocyte colony forming cells in the bone marrow of patients with Felty's syndrome was less than that found in the bone marrow of patients with idiopathic neutropenia or splenomegaly or other disorders. They suggested that 'decreased production appears to contribute significantly to the neutropenia present in patients with Felty's syndrome', while not explaining the possible nature of this defect. Using this same system, a factor has been described in normal human and animal serum and urine which will stimulate the growth of granulocytic and macrophage colonies in vitro (Foster, Metcalf, Robinson, and Bradley, 1968; Stanley, Robinson, and Ada, 1968; Robinson and Pike, 1970) .
This factor has been characterized as a glycoprotein with a molecular weight of approximately 45000 which migrates electrophoretically as an a-globulin (Stanley and others, 1968; Stanley and Metcalf, 1969) . A large body of evidence exists which strongly suggests that this factor represents, or is, a true granulopoietin stimulating maturation and production of the granulocyte cell line in vivo as well as in vitro (Metcalf and Stanley, 1971; Metcalf and Moore, 1971; Robinson, 1974 Tables I, II , and III. The method for determination of urinary granulopoietic stimulating activity has been published in detail elsewhere (Foster and others, 1968; Robinson and Pike, 1970) . In brief, 0-15 ml of dialysed, sedimented, filter sterilized urine is placed in triplicate 35 mm plastic Falcon petri dishes to which is added a mixture of 0 3 % agar, McCoy's 5A medium, and 75000 nucleated bone marrow cells from the femurs of C57/bl mice. The total volume in each petri dish is 1 ml. After mixing urine with the culture medium, the plates are allowed to gel at room temperature and then incubated at 37°C in a fully humidified incubator for 7 days. Colony counts are then done as an index of the level of granulopoietic material present in the specimen. Only colonies containing 50 or more cells are counted. Previous data have shown a linear relationship between the number of such colonies counted and the amount ofgranulopoietic activity present, allowing a quantitative estimate (Stanley and Metcalf, 1969) . Table I shows the clinical details, haematological parameters, and colony stimulating activity of nine patients with Felty's syndrome. Also shown are minimal details of bone marrow biopsy studies when these were available. It can be seen that the majority of these patients had bone marrows which were read as hyperplastic with a maturation arrest in the granulocytic series. Table II shows the same data, without bone marrow biopsies, in nine control patients with rheumatoid arthritis. All patients studied here had absolute granulocyte counts above 2-5 x 109/l (2500/mm3) and the majority were above 5 0 x 109/l (5000). Table III shows the haematological parameters and bone marrow findings of twelve patients without rheumatoid arthritis who had neutropenic disorders, and shows that the majority of these patients had hypoplastic bone marrows either on the basis of idiopathic neutropenia or as the result of chemotherapy. Fig. 1 shows the levels ofurinary colony stimulating activity in these three groups of patients. The mean value of urinary colony stimulating activity of seven patients with Felty's syndrome was 10-1 and is significantly lower than that found in patients with rheumatoid arthritis and in patients with neutropenic Fig. 2 shows the serum colony stimulating activity of the same three groups of patients. Eight patients with Felty's syndrome had a mean serum colony stimulating activity level of 4 0, which is significantly lower than that of other neutropenic patients but is not significantly different from that of other patients with rheumatoid arthritis or normal humans (range 0-10 with a mean of 5 in our laboratory). The inability to show clearly low levels of serum CSA probably reflects the insensitivity of the assay system when low concentrations of granulopoietic factors are present.
Results

Discussion
It has long been assumed that granulocytopenia occurring in Felty's syndrome was the result of a hypersplenic state; and on this basis splenectomy has frequently been performed. However, several reports have indicated the lack of uniform success with this method in alleviating the granulocytopenia and the recurrent infections that occur in association with this syndrome (Barnes and others, 1971; Moore, Brunner, Sandusky, and Leavell, 1971) . In most reported series the neutrophil count retums to normal after splenectomy in 60-70% of patients, although most patients have a transient increase in neutrophils in the peripheral blood. These data suggest that Felty's syndrome, at least in some cases, is not simply the result of hypersplenism alone, and previous data have suggested that this might be the result of an antinuclear factor, specific for leucocytes, found in high titres in the serum of patients with rheumatoid arthritis, specifically in patients with Felty's syndrome (Faber and others, 1964; Barnes and others, 1971) . The direct pathogenic role played by this serum factor in the development of Felty's syndrome, however, is still open to question. The finding of Greenberg and Schrier (1973) of normal or low numbers of granulocyte colony forming cells in the bone marrow of patients with Felty's syndrome also suggested that hypersplenism alone does not produce granulocytopenia in this disorder. It would be expected, in contradistinction to their findings, that if the disorder were due to increased destruction of granulocytes, that increased numbers of granulocyte-producing cells might be found in the bone marrow of these patients. In the patients reported here, no study was done of the colony forming capacity of bone marrow cells. However, the majority of these patients had bone marrows which were read as hyperplastic, which must be viewed with caution in light of the findings reported by Greenberg and Schrier and those reported here. It is suggested that this is more likely the result of a maturation arrest in the granulocyte series rather than increased cellular proliferation. The evidence that factors other than hypersplenism may lead to the development of granulocytopenia in this disorder led us to study the levels of granulopoietic factors. Previous studies have indicated a physiological role for the colony stimulating factor described here in the stimulation of maturation and production of the granulocyte cell line (Metcalf and Moore, 1971; Metcalf and Stanley, 1971; group.bmj.com on April 9, 2017 -Published by http://ard.bmj.com/ Downloaded from 1974). Furthermore, it has been shown that the levels of this factor in the serum and urine of animals and humans with various granulocytopenic disorders are highest during times when the granulocyte levels are decreased (Dale, Brown, Carbone, and Wolff, 1971 ; Shadduck and Nagabhushanam, 1971 ; Quesenberry, Morley, Stohlman, Rickard, Howard, and Smith, 1972) . Contrary to the expectation of high levels of granulopoietic factor in the urine of these patients, not only on the basis of peripheral granulocytopenia, but also on the basis of increased destruction ofthese cells within the spleen, we found markedly reduced levels in this disorder.
Recent data suggest that the major source of colony stimulating factor in humans is the monocytemacrophage system (Golde and Cline, 1972; Chervenick and LoBuglio, 1972; Moore, Williams, and Metcalf, 1973) . On the basis of cell separation studies, it appears that these cells actively manufacture this material by a process of secretion in response to increased demands. Several possible explanations may be offered. The first possible mechanism is decreased or altered production of such factors by the reticuloendothelial system. Such a mechanism, however, does not satisfactorily explain the response of 60-70 % of patients with this disorder to splenectomy. If such a mechanism were involved, removal of this organ with its large component of reticuloendothelial cells might be expected to aggravate rather than alleviate granulocytopenia. A second possible explanation is the production of a factor inhibiting normal granulopoiesis which is partially, but not wholly, produced by the spleen itself. Inhibitory factors against the colony stimulating material have been previously described but have not been well characterized as to specificity, biochemical nature, source, or mode of action (Metcalf and Moore, 1971) , and though this was not investigated in the present study, it is a possible mechanism and is being investigated at the present time.
Such inhibitory material might be directed either against the granulocyte precursor cells in the bone marrow or the colony stimulating factor itself. The present data do not give any indication as to which of these might be operative. Mixture of serum or urine from patients with Felty's syndrome with other materials of known colony stimulating activity to determine the presence of inhibitory materials would not answer this question. More sophisticated techniques are required and are now being employed.
Consideration should be given to the possibility that the splenomegaly occurring in this disorder is the result of the granulocytopenia rather than the cause. Splenomegaly, with resultant extramedullary haematopoiesis, is known to occur in a variety of disorders in which production of haematopoietic cellular elements is interfered with. Removal of this spleen would be expected to increase peripheral granulocyte numbers due to increased life span of these cellular elements without effectively altering granulocyte production. Although this may be a useful therapeutic manoeuver in this disorder, as it is in idiopathic thrombocytopenic purpura, it may not attack the primary problem (Crosby, 1973) . We would not suggest at the present time changes in the current recommended indications for splenectomy in Felty's syndrome as this may, as previously shown, be a lifesaving manoeuvre in these patients. Serious consideration should, however, be given to other mechanisms for the development of granulocytopenia in patients with Felty's syndrome. Studies are now underway to further delineate the role of granulopoietic factors and cellular responsiveness in this disorder. Supported by grants from the National Institutes of Health, National Cancer Institute (IR01CA11305-5 and CA05058-10), the American Cancer Society Grant
